Bhaskar DasGupta

Active 1989–2026

Also published as
Bhaskar Dasgupta
243
Papers
22,079
Citations
71
h-index
164
i10-index

Citations

Citations per year for Bhaskar DasGupta1978: 1 citations1990: 1 citations1991: 1 citations1993: 10 citations1994: 9 citations1995: 4 citations1996: 9 citations1997: 6 citations1998: 11 citations1999: 12 citations2000: 32 citations2001: 19 citations2002: 45 citations2003: 51 citations2004: 56 citations2005: 46 citations2006: 32 citations2007: 96 citations2008: 74 citations2009: 110 citations2010: 120 citations2011: 115 citations2012: 138 citations2013: 132 citations2014: 126 citations2015: 146 citations2016: 168 citations2017: 219 citations2018: 196 citations2019: 605 citations2020: 757 citations2021: 787 citations2022: 617 citations2023: 659 citations2024: 889 citations2025: 426 citations2026: 34 citations1979–1989: no citations, so these years are not shown1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,249 citing papers, 17.1% of this breakdownUnited Kingdom: 610 citing papers, 8.3% of this breakdownChina: 527 citing papers, 7.2% of this breakdownGermany: 465 citing papers, 6.4% of this breakdownItaly: 458 citing papers, 6.3% of this breakdownFrance: 442 citing papers, 6% of this breakdownNetherlands: 285 citing papers, 3.9% of this breakdownSpain: 280 citing papers, 3.8% of this breakdownJapan: 243 citing papers, 3.3% of this breakdownCanada: 241 citing papers, 3.3% of this breakdownSwitzerland: 175 citing papers, 2.4% of this breakdownIndia: 173 citing papers, 2.4% of this breakdown
0%17.1%Other 29.6%

Fields

  • Medicine57.1%
  • Computer Science14.1%
  • Engineering13.6%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Immunology and Microbiology2%
  • Physics and Astronomy1.5%
  • Other3.9%

Topics

  • Vasculitis and related conditions10%
  • Otitis Media and Relapsing Polychondritis4.3%
  • Rheumatoid Arthritis Research and Therapies4.2%
  • Systemic Lupus Erythematosus Research3%
  • Robotic Mechanisms and Dynamics2.6%
  • Systemic Sclerosis and Related Diseases2.1%
  • Other73.8%

Coauthors

All papers

Open in search
  1. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 1,170

  2. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Durez, Maya H Buch, Hasan Rizvi, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Vasco C. Romão, João Eurico Fonseca, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar DasGupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Julio Ramírez, Raquel Celis, Robert J. Moots, Peter C. Taylor, C J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Gaye Hadfield, Costantino Pitzalis - Nature Medicine 2022 cited by 279

  3. Trial of Tocilizumab in Giant-Cell Arteritis

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 1,375

  4. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 339

  5. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, João Eurico Fonseca, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Liliane Fossati‐Jimack, Gaye Hadfield, Georgina Thorborn, Julio Ramírez, Raquel Celis - The Lancet 2021 cited by 315

  6. Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2008 cited by 1,214

  7. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 cited by 965

  8. Tocilizumab (Actemra)

    Authors: , , , , - Human Vaccines & Immunotherapeutics 2017 cited by 329

  9. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

    Authors: , , , , - Lara D. Veeken 2016 cited by 364

  10. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Damjan Vukcevic, Mohammed Akil, Jonathan Barratt, Neil Basu, Adam S. Butterworth, Ian N Bruce, Michael Clarkson, Niall Conlon, Bhaskar Dasgupta, Timothy Doulton, Georgina Espígol‐Frigolé, Oliver Floßmann, Armando Gabrielli, Jolanta Gąsior, Gina Gregorini, Giuseppe Guida, José Hernández‐Rodríguez, Zdenka Hrušková, Amy W. Hudson, Ann Knight, Peter Lanyon, Raashid Luqmani, Malgorzata Magliano, Angelo A. Manfredi, Christopher Marguerie, Federica Maritati, Chiara Marvisi, Neil McHugh, Eamonn Molloy, Allan Motyer, Chetan Mukhtyar, Leonid Padyukov, Alberto Pesci, Sergio Prieto‐González, Marc Ramentol-Sintas, Petra Reis, Dario Roccatello, Patrizia Rovere‐Querini, Carlo Salvarani, Francesca Santarsia, Roser Solans‐Laqué, Nicole Soranzo, Jo Taylor, Julie Wessels, Jochen Zwerina, Benjamin Terrier, Richard A. Watts, Augusto Vaglio, Julia U. Holle, Chris Wallace, Kenneth G. C. Smith - Nature Communications 2019 cited by 271

  11. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 114

  12. Disease stratification in GCA and PMR: state of the art and future perspectives

    Authors: , , , , , , , , , , - Nature Reviews Rheumatology 2023 cited by 115

  13. Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 122

  14. The provisional OMERACT ultrasonography score for giant cell arteritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nevsun İnanç, Aaron Juche, Rositsa Karalilova, Toshio Kawamoto, Kresten Krarup Keller, Helen Keen, Tanaz A. Kermani, Minna J. Kohler, Matthew J. Koster, Raashid Luqmani, Pierluigi Macchioni, Sarah Mackie, Esperanza Naredo, Berit Dalsgaard Nielsen, Michihiro Ogasawara, Carlos Pineda, Valentin Sebastian Schäfer, Luca Seitz, Alessandro Tomelleri, Karina D. Torralba, Kornelis S. M. van der Geest, Kenneth J. Warrington, Wolfgang Schmidt - Annals of the Rheumatic Diseases 2022 cited by 91

  15. Polymyalgia Rheumatica and Giant Cell Arteritis

    Authors: , , , - JAMA 2016 cited by 488

  16. The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study

    Authors: , , , , , , , , , , , , , , , , , , - Health Technology Assessment 2016 cited by 449

  17. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 113

  18. Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claire Gorman, James Galloway, Hector Chinoy, Désirée van der Heijde, Peter Sasieni, Anne Barton, Costantino Pitzalis, Ahmed S Zayat, Ana Rita Marinho Machado, Andrea Cuervo, Arti Mahto, Cankut Çubuk, Charlotte Rawlings, Chijioke H Mosanya, Christopher D. Buckley, Chris Holroyd, Debbie Maskall, Francesco Carlucci, Georgina Thorborn, Gina Tan, Gloria Lliso-Ribera, Hasan Rizvi, Joanna Peel, João Eurico Fonseca, John D. Isaacs, Julio Ramírez, Laurent Méric de Bellefon, Liliane Fossati-Jimak, Mary Ng’endo Githinji, Mattia Congia, Neal L. Millar, Nirupam Purkayastha, Raquel Celis, Rakhi Seth, Rebecca Hands-Greenwood, Robert Landewé, Simone Perniola, Stefano Alivernini, Stefano Marcia, Stefano Marini, Stephen Kelly, Vasco C. Romão - The Lancet Rheumatology 2023 cited by 68

  19. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 331

  20. Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - RMD Open 2018 cited by 231

  21. Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial

    Authors: , , , , , , , , , , , - The Lancet Rheumatology 2021 cited by 133

  22. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities

    Authors: , , , , , - Nature Reviews Rheumatology 2017 cited by 227

  23. Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Isenberg, V. Saravanan, David Coady, Bhaskar Dasgupta, Neil McHugh, Steven Young‐Min, Robert J. Moots, Nagui Gendi, Mohammed Akil, Bridget Griffiths, Svein Joar Auglænd Johnsen, Katrine Brække Norheim, Roald Omdal, Deborah Stocken, Colin Everett, Catherine Fernandez, John D. Isaacs, Jacques‐Eric Gottenberg, Valérie Devauchelle-Pensec, Philippe Dieudé, Jean Jacques Dubost, Anne-Laure Fauchais, Vincent Goëb, É. Hachulla, Claire Larroche, Véronique Le Guern, Jacques Morel, Aleth Perdriger, Xavier Puéchal, S. Rist, Damien Sen, Jean Sibilia, Olivier Vittecoq, Joëlle Bénessiano, Sarah Tubiana, Karine Inamo, Stanie Gaëte, Djilali Batouche, Domitille Molinari, Mickael Randrianandrasana, Isabelle Pane, Adeline Abbé, Gabriel Baron, Philippe Ravaud, Jacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, Véronique Le Guern, Jean Sibilia, Claire Larroche, Alain Saraux, Valérie Devauchelle-Pensec, Jacques Morel, Gilles Hayem, P.Y. Hatron, Aleth Perdriger, Damien Sene, Charles Zarnitsky, Djilali Batouche, Valérie Furlan, Joëlle Bénessiano, Élodie Perrodeau, Raphaèle Séror, Xavier Mariette, Samuel M. Brown, N. Navarro, C Pitzalis, Paul Emery, Sue Pavitt, Joanne Gray and 141 more - The Lancet Rheumatology 2019 cited by 137

  24. The Stewart platform manipulator: a review

    Authors: , - Mechanism and Machine Theory 2000 cited by 702